Dermatology Flashcards

1
Q

Alopecia areata

A

incidence: 1%

trigger: emotional stress

pathogenesis: chronic AI disorder with T cells targeting anagen hair follicles with transition into the telogen phase

associations: atopy, nail changes, cataracts/lens opacification, AI diseases, T21

family history: 10-20%

clinical: rapid, complete hair loss in round/ oval patches

- no inflammation so the scalp is smooth and quite bald

  • spontaneous resolution 6-12 mths

treatment: usually reassurance only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Congenital bullous ichthyosiform erythroderma

A

genetics: AD defect in keratin 1 or 10 on chromosome 12p

clinical:

  • birth: generalised erythroderma/severe hyperkeratosis with hyperkeratotic ridges over joint flexures (axillary, popliteal, CF, neck, hips)
  • recurrent blistering may be widespread in neonates

treatment: difficult, AB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contact dermatitis

A

pathophysiology: T-cell-mediated hypersensitivity reaction from Ag on skin surface triggering activation of sensitised T cells within 8-12hours

clinical: erythematous, pruritic, eczematous dermatitis which if severe can be vesiculobullous

treatment: treat for 10-14 days

  • steroids (if <10% of skin and not spreading may use ointment)
  • symptomatic treatment: antihistamines, wet dressings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Erythema marginatum

A

cause: acute rheumatic fever

time: early in disease

clinical: evanescent, pink or faintly red, nonpruritic annulare rash involving the trunk and sometimes the limbs, but not the face usually occurs early in the course of ARF

  • lesions disappear and reappear in a matter of hours
  • often associatred with acute carditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Erythema Multiforme

A

definition: acute immune-mediate condition characterised by target-like lesions on skin or mucosa

prevalence: <<1%, age 20-40yrs

causes:

  • infection/immunisations (90%): most commonly HSV, mycoplasma
  • malignancies
  • drugs (<10%): NSAIDs, sulfonamides, AED, AB (most commonly penicillin)
  • AI disease

clinical: target lesions in symmetrical distribution on extensor surfaces or extremities

  • lasting 5 days to 2 weeks
  • prodromal syndromes are uncommon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Infantile haemangiomas

A

definition: vascular dysplasia from proliferating capillary endothelium (angioblastic cells)

prevalence: 10% children <1 yr

natural history: grow in first 6- 12 months then involute 10% per year after

  • 50% resolved 5 years, 70% by 7 years, 90% by 9 years
  • 10- 40% will have residual changes (telangiectasia, pallor, atrophy, skin redundancy)

indications for treatment:

  • Kasabach-Merrit sx
  • affecting the eye/airway/lip/ear/nasal cartilage
  • recurrent bleeding, ulceration, infection
  • high CO

treatment:

  • 1st line: PO propranolol 1-2mg/kg/day for 3-6 months (60% effective)
  • other: IFN-g, laser, surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pimecrolimus

A

use: second-line agent for short-term and intermittent treatment of mild to moderate atopic dermatitis in non-immunocompromised patients

mechanism: topical calcineurin inhibitors

benefit: does NOT cause skin atrophy

adverse reactions: facial edema, headache, fever, pruritis, folliculitis, discolouration, nausea, burning, coryza, LN, anaphylactoid reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Rash of zinc deficiency

A

causes:

acquired: breast milk deficient in zinc (mother with Crohn’s)

inherited: AR acrodermatitis enteropathica hereditary zinc deficiency

  • weaning from breast to cow’s milk

clinical:

  • cutaneous eruption: vesiculobullous, eczematous, dry, scaly, or psoriasiform skin lesions symmetrically distributed in the perioral, acral, perineal areas, cheeks, knees and elbows
  • diarrhea, stomatitis, glossitis, paronychia, nail dystrophy, growth retardation, irritability

diagnosis: low zinc level

treatment: oral zinc sulfate 1-2mg/kg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Rashes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Staph perianal disease

A

organism: group A B-haemolytic streptococcus

transmission: digital contamination from an infected oropharynx

incidence: male>females, 3-4yrs

clinical: 3 presentations

1. bright pink erythema extending 2-3 cm from the anus, skin tender but not indurated

2. painful anal fissuring and dried mucoid discharge of perianal skin

3. erythematous psoriasiform eruption extending several cm from anal rim with yellow superficial crusting at the peripheral border with satellite crusted lesions

  • pain on defecation universal complaint

diagnosis: perianal swab

treatment: penicillin V 50mg/kg/day + topical mupurocin BD 10/7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Staphylococcus Scalded Skin Syndrome

A

incidence: day 3 to 5 years

pathology: staph aureus exfoliative toxins

pathogenesis: toxins act on the granulosa of the epidermis causing cleavage of desmoglein complex 1

clinical: malaise, fever, irritability then rash

  • scarlatiniform erythema diffuse to flexural and periorifical areas, conjunctivitis, flaccid blisters, erosions, nikolsky sign

diagnosis:

  • histology: cleavage plane in the lower stratum granulosum with minimal inflammation/necrosis

progression:

  • day 2-5: desquamation , day 10-14: healing w/o scarring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Steven Johnson Syndrome

Toxic Epidermal Necrosis

A

definition: SJS, Toxic Epidermal Necrolysis, SJS/TEN overlap syndrome

pathogenesis: uncertain etiology with desquamative lesions of skin/mucous membranes

distribution: <10% epidermis SJS, >30% TEN, 10-30% overlap SJS/TEN

cause:

  • infections: mycoplasma
  • drugs: sulfonamides, NSAIDs, Ab, AEDs especially lamotrigine

clinical:

  • prodrome of fever and influenza-like symptoms 1-3 days
  • mucocutaneous/skin vesicular and bullous lesions followed by sloughing
  • may be multiorgan involvement
  • resolved 2-4 weeks

risk factors: HIV, genetic factors, viral infections, immunologic diseases

diagnosis: clinical, histology only supportive

management: w/d potentially causative agents, AB, IVIg

mortality: SJS 1-3%, TEN 25-35%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sturge Weber Syndrome

A

cause: sporadic mutation GNAQ gene

clinical: port wine stain, glaucoma, seizures, MR, ipsilateral leptomeningeal angioma

symptoms: serizures 80%, headache 60%, DD 50%, glaucoma 50%, hemianopsia 50%, hemiparesis 50%

type 1: (most common) facial/leptomeningial angiomas, glaucoma

type 2: facial angioma, possible glaucoma

type 3: leptomeningeal angioma

pathophysiology: error in mesodermal/ectodermal development

  • port wine stain: abundance of capillaries around opthalmic branch trigeminal nerve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tinea

A

organism: dermatophyte fungi

clinical: pruritic erythematous papules, pustules, annular or geographical lesions

  • unilateral/asymmetrical

treatment: topical antifungals (whitfield’s ointment, Imidazole creams) for small patches

  • oral griseofulvin for severe skin infection or hair infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Urticaria pigmentosa

(mastocytosis)

A

aka: maculopapular cutaneous mastocytosis

pathogenesis: aggregates of mast cells in the dermis

classic infantile type: lesions erupt 1st several months-2 yrs

  • bullous/urticarial lesions that become hyperpigmented
  • larger nodular lesions, like mastocytomas may have orange-peel texture
  • stroking to the nodule causes urtication (Darier sign) from histamine release

adult type: caused by mutation in stem cell factor

  • does not resolve and new lesions continue to develop throughout adult life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Topical steroids

A

weak: hydrocortisone 0.5% or 1%

  • face and nappy area

moderate: betamethasone valerate 0.02% or propionate 0.05% or 1%

  • body

strong: mometasone 0.1% @ night (elocon)

  • to body only
17
Q

Infantile haemangiomas

A

definition: benign tumours of vascular endothelium

prevalence: 10% of <1 year olds

clinical: 95% involute spontaneously after period of initial growth

  • growth 6-12 months
  • 50% by 5 yrs
  • 70% by 7 yrs
  • 90% by 9 yrs

indications for treatment:

  • large/rapidly growing
  • lesions in the lip/nose/periorbital region/airway/liver/GI
  • risk of ulceration, scarring or disfigurement

treatment:

  • topical (localised/uncomplicated): topical beta blockers, CS, imiquimod
  • propranolol
18
Q

Incontinentia pigmenti

A

genetic: IKBKG gene with X-linked activation in females (lethal in males)

definition: hereditarable, multisystem ectodermal dermatologic, dental, and ocular abnormalities

clinical:

- 1st stage birth- erythematous linear streaks and plaques of vesicles that are most pronounced on limbs and cirumferentially on the trunk. Resolves 4 mths

- 2nd stage: blisters become dry hyperkeratotic, forming verrucous plaques. Involute by 6 mths

- 3rd stage: hyperpigmentation on trunk with macular whorls, reticulated patches, flecks, streaks that folllow blaschko line. Fade by early adolescence and often disappear by age 16

- 4th stage: hairless, anhidrotic, hypopigmented patches

associations:

  • alopecia 40%
  • dental anomalies 80%: hypodontia, conical teeth
  • CNS: MR, seizures, microcephaly, spasticity in 1/3
  • ocular anomalies in >30%

diagnosis: clinical gournds; Wood lamp highlight pigmentary abnormalities

19
Q

Telogen effuvium

A

definition: sudden loss of large amount of hair

pathogenesis: premature conversion of growing, or anagen hairs to resting, or telogen hairs

causes: 6wks-3 mo after precipitating cause

  • eg. childbirth, fever, severe weight loss, blood loss, psychiatric stress

prognosis: ormal hair growth will return within 6 months

20
Q

Acute palmoplantar eczema

(pompholyx)

A

prevalence: young adults

clinical: intensly pruritic vesicular eruption to palms/soles

  • vesciles/bullae for several weeks which resolve with desquamation

treatment: topical steroids, calcineurin inhibitors

21
Q

Eczema

A

age: early onset

incidence: 15%

clinical: pruritis, eczema, atopy, xerosis

pathogenesis:

  • defect stratum cornea: outer defect
  • filaggrin deficiency: aligns keratin, moisturises

treatment: eczema should resolve within 2 weeks

22
Q

Psoriasis

A

incidence: 1%

associations: arthritis in 40%

risk factors: smoking, stress, skin trauma

treatment: topical, PT (UVB), systemic tx

  • NEVER use systemic steroids (pustular flare)

prognosis: increased risk metabolic disorders

23
Q

PHACE syndrome

A

P: posterior fossa malformation

H: haemangioma

A: arterial anomalies

C: CV anomalies

E: eye anomalies

S: sternal cleft

24
Q

Sebaceous Naevi

A

incidence: 0.3%

appearance: pink/orange plaques with velvety surface

  • no hair

location: majority head/necks

associations: epidermal naevus syndrome (seizures, ID, spastic hemiparesis, deafness, CNS abnormalities)

treatment: excision before puberty

25
Q

Becker naevus

A

appearance: asymmetrical persistant areas of pigmentation presenting in childhood/adolescence

risk factors: increased androgen sensitivity

sex: M:F = 5:1

26
Q

Ossification Centres

A

C: capitellum (age 1)

R: radial head (age 3)

I: internal epicondyle (age 5)

T: trochlear (age 7)

O: olecranon (age 9)

E: external epicondyle (age 11)